Use of unconventional therapies by children with cancer at an urban medical center

被引:114
作者
Kelly, KM
Jacobson, JS
Kennedy, DD
Braudt, SM
Mallick, M
Weiner, MA
机构
[1] Babies & Childrens Hosp, Div Pediat Oncol, New York, NY USA
[2] New York Presbyterian Hosp, Columbia Presbyterian Ctr, New York, NY USA
[3] Columbia Univ, Sch Publ Hlth, Div Epidemiol, New York, NY USA
[4] Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY USA
关键词
unconventional therapies; complementary and alternative medicine; children; pediatric oncology; cancer;
D O I
10.1097/00043426-200009000-00005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The aim of this study was to determine the prevalence, modalities, and determinants of use of unconventional therapies among children with cancer receiving conventional treatment at an urban academic medical center in the United States. Patients and Methods: We interviewed the parents of patients and/or patients who were receiving or had received conventional therapy for treatment of childhood cancer. Of 78 patients/parents asked, 75 consented to the interview, which included demographic factors, life events, and use of unconventional therapies. All participants also consented to the abstraction of chart data for this study. Results: Overall, 84% of respondents reported the use of one or more unconventional therapies. The most commonly used modalities were changes in diet, nutritional and herbal agents, and mind/body treatments. Most users had tried more than one unconventional modality. No difference in use was seen by cancer, diagnosis, race/ethnicity, socio-economic status, or educational attainment of the respondent. Of the therapies used, 50% were not reported to the physicians. Of patients reporting use of an unconventional approach, 85% were concurrently enrolled on clinical trials for primary treatment of their cancer. Conclusions: The use of unconventional therapies is highly prevalent among children with cancer and is not associated with demographic or clinical factors or participation in clinical trials. The possibility that an unconventional treatment may interact with a protocol treatment underscores the need for more information about the use of such therapies among all patients.
引用
收藏
页码:412 / 416
页数:5
相关论文
共 20 条
[11]   Use of alternative treatment in pediatric oncology [J].
Grootenhuis, MA ;
Last, BF ;
de Graaf-Nijkerk, JH ;
van der Wel, M .
CANCER NURSING, 1998, 21 (04) :282-288
[12]  
JACOBSON JS, 1999, P AM SOC CLIN ONCOL, P1228
[13]  
KOSARY CL, 1995, NIH PUBLICATION
[14]  
Mottonen M, 1997, MED PEDIATR ONCOL, V28, P205, DOI 10.1002/(SICI)1096-911X(199703)28:3&lt
[15]  
205::AID-MPO10&gt
[16]  
3.0.CO
[17]  
2-D
[18]  
Orbach O, 1999, NEW ENGL J MED, V340, P569
[19]   Cancer patients use of nonproven therapy: A 5-year follow-up study [J].
Risberg, T ;
Lund, E ;
Wist, E ;
Kaasa, S ;
Wilsgaard, T .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) :6-12
[20]   THE USE OF ALTERNATIVE THERAPIES BY CHILDREN WITH CANCER [J].
SAWYER, MG ;
GANNONI, AF ;
TOOGOOD, IR ;
ANTONIOU, G ;
RICE, M .
MEDICAL JOURNAL OF AUSTRALIA, 1994, 160 (06) :320-322